A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD

Clinical trial NCT05470114 · COMPLETED

Trial details

NCT number: NCT05470114
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2022-05-19
Primary completion: 2023-06-07
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.